WASHINGTON - The U.S. Food and Drug Administration plans to approve a new use for the generic drug leucovorin as a treatment for kids with autism.

Trump, Health and Human Services Secretary Robert F. Kennedy Jr. and other health officials discussed the medication during a press conference on Monday.

Trump administration discusses leucovorian as treatment for autism

What they're saying:

"I'm also here to announce good news today. The FDA is filing a Federal Register notice to change the label on an exciting treatment called prescription leucovorin so that it can be available to children with autism," FDA Commissioner Marty Makary said, adding, "We have thousands of kids, in my opinion, who will benefit."

Following the press conference, the FDA initiated the approval of leucovori

See Full Page